期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

强化膜肺血液相容性和耐久性的研究进展

The Development of Research on Membrane Oxgenator Application
暂未订购
导出
摘要 交叉流管外血流式中空纤维膜肺(ELFHFMO)以其独特优点已被国内外医学界广泛使用,但临床应用中面临着血液相容性不够和耐久性不好的问题,本文以如何解决这两个问题为线索,综述了近年来的研究进展。 Extra-luminal flow hollow fiber membrane oxygenator （ELFHFMO） has been widely applied in cardiopulmonary bypass （CPB） and extracorporeal membrane oxygenation（ECMO） or extracorporeal life support （ECLS） because of its advantages over other types of MO. But its low hemocompatibility and durability are the major problems in clinical application that even have limited its wide application. In this paper, we reviewed the recent researches on how to improve the hemocompatibility and durability of ELFHFMO.
作者 王丽红 陈欢林 王克诚
机构地区 浙江大学材料与化工学院 唐山师范学院化学系
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2007年第1期240-244,共5页 Journal of Biomedical Engineering
关键词 膜肺 生物相容性 肝素 生物细胞膜模拟 数学模型 Membrane oxygenator （MO） Hemocompatibility Heparin Cell membrane simulation Mathematic model
分类号 R318.1 [医药卫生—生物医学工程]
  • 相关文献

参考文献28

  • 1Arpad P,Georg L,Heinz S,et al.Bilateral lung transplantation with intra-and postoperatively prolonged ECMO support in patients with pulmonary hypertensionq.European Journal of Cardio-thoracic Surgery,2002;21 (5):858
  • 2Carin W,Michael PB,Jack W.A long-term stable normothermic cardiopulmonary bypass model in neonatal swine.Journal of Surgical Research,2001;101(2):176
  • 3Dong GH,Xu B,Wang CT,et al.A rat model of cardiopulmonary bypass with excellent survival.Journal of Surgical Research,2005;123(2):171
  • 4Wendel HP,Xiemer G.Coating-techniques to improve the hmeocompatibility of artificial devices used for extracorporeal circulation.European Journal of Cardio-thoracic Surgery,1999;16(3):342
  • 5Belboul A,Lofgren C,Storm C,et al.Heparin-coated circuits reduce occult myocardial damage during CPB:a randomized,single blind clinical trial.European Journal of Cardio-Thoracic Surgery,2000;17(5):580
  • 6Tamin M,Demircin M,Gurener M.Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.Panminerva Medica,1999;41(3):193
  • 7Belboul A,al-Khaja N.Does heparin coating improve biocompatibility? A study on complement,blood cells and postoperative morbidity during cardiac surgery.Perfusion,1997;12(6):385
  • 8Van den J,Nieuwland R,Van den A.Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.European Journal of Cardio-thoracic Surgery,2004;26(5):926
  • 9Fosse E,Thelin S,Svennevig JL,et al.Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation,but does not affect the release of granulocyte enzymes:a European multicentre study.European Journal of Cardio-Thoracic Surgery,1997;11(2):320
  • 10Belboul A,Akbar O,Lofgren C,et al.Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass.Journal of Cardiovascular Surgery,2000;41(3):357
生物医学工程学杂志
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部